Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,088.10
-10.25 (-0.93%)
Apr 13, 2026, 3:29 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 592.95 billion as of April 13, 2026. Its market cap has increased by 81.91% in one year.
Market Cap
592.95B
Enterprise Value
615.72B
Revenue
67.22B
Ranking
n/a
PE Ratio
70.36
Stock Price
1,088.10
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 592.95B, an increase of 1,149.95%. That is a compound annual growth rate of 31.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 587.26B | -1.82% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 993.17B |
| Zydus Lifesciences | 921.11B |
| Mankind Pharma | 858.27B |
| Aurobindo Pharma | 783.73B |
| Alkem Laboratories | 650.43B |
| Glenmark Pharmaceuticals | 610.46B |
| Ipca Laboratories | 369.44B |
| Ajanta Pharma | 350.44B |